BerGenBio’s Board of Directors is composed of experienced biopharmaceutical executives with experience of developing next generation cancer drugs and building world class innovative oncology biotechnology companies. The Board also represents leading investors and has substantial commercial experience to navigate the development of the Company.
Board of Directors
Mrs. Hilde Furberg
Non-Executive Director
Hilde Furberg has broad senior leadership experience, coming from her…
Read More
Dr. Susan Foden
Non-Executive Director
Dr. Susan Foden holds a number of Non-Executive Directorships with…
Read More
Mrs. Kari Grønås
Non-Executive Director
Kari Grønås (M. Sc. Pharm) has more than 25 years…
Read More
Dr. Stener Kvinnsland
Non-Executive Director
Dr. Stener Kvinnsland has more than 30 years of experience…
Read More
Mr. Sveinung Hole
Non-Executive Director
Sveinung Hole is the CEO of Bergen Research Foundation and…
Read More
Mr. Jon Øyvind Eriksen
Non-Executive Director, CFA
Jon Øyvind Eriksen is an Investment Director and head of…
Read More
Jonas Lies vei 91, 5009 Bergen, Norway
+ 47 559 61 159 (general) + 47 535 01 564 (urgent medical enquiries)